A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana Press When Injected Every Four Months
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 May 2019
Price : $35 *
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 20 May 2019 Planned End Date changed from 30 Jul 2020 to 30 Apr 2020.
- 20 May 2019 Planned primary completion date changed from 30 Jul 2019 to 30 Apr 2020.
- 20 May 2019 Status changed from recruiting to active, no longer recruiting.